Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kogawara, Osamu"'
Autor:
Yonekawa, Motoharu, Watanabe, Tohru, Kogawara, Osamu, Yoshii, Chihiro, Yamaji, Masako, Aizawa, Masakazu, Erber, Wilhelm, Ito, Shuhei, Jug, Bogdan, Koelch, Doris, de Solom, Richard, Lockhart, Stephen P.
Publikováno v:
In Vaccine 10 May 2024 42(13):3180-3189
Autor:
Ishihara, Yasunori, Fukazawa, Mitsuru, Enomoto, Shinya, de Solom, Richard, Yamaji, Masako, Kline, Mary, Aizawa, Masakazu, Peng, Yahong, Kogawara, Osamu, Giardina, Peter C., Tamimi, Noor, Gruber, William C., Watson, Wendy
Publikováno v:
In International Journal of Infectious Diseases April 2024 141
Autor:
Haranaka, Miwa, Young Song, Joon, Huang, Kuo-Chin, de Solom, Richard, Yamaji, Masako, McElwee, Kathleen, Kline, Mary, Aizawa, Masakazu, Peng, Yahong, Scully, Ingrid, Kogawara, Osamu, Gruber, William C., Scott, Daniel A., Watson, Wendy
Publikováno v:
In Vaccine 15 February 2024 42(5):1071-1077
Autor:
Togashi, Takehiro, Mitsuya, Nodoka, Kogawara, Osamu, Sumino, Shuji, Takanami, Yohei, Sugizaki, Kayoko
Publikováno v:
In Vaccine 31 August 2016 34(38):4635-4641
Autor:
Haranaka, Miwa, Baber, James, Ogama, Yoichiro, Yamaji, Masako, Aizawa, Masakazu, Kogawara, Osamu, Scully, Ingrid, Lagkadinou, Eleni, Türeci, Ӧzlem, Şahin, Uğur, Dormitzer, Philip R., Gruber, William C., Lockhart, Stephen
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-7 (2021)
Nature Communications
Nature Communications
We report interim safety and immunogenicity findings from an ongoing phase 1/2 study of BNT162b2 in healthy Japanese adults. Participants were randomized 3:1 to receive 2 intramuscular injections of 30 μg BNT162b2 or placebo 21 days apart. Overall,